Cancer Treatment Centers of America® (CTCA) Phoenix is the first hospital in the western half of the U.S. and the first hospital in Arizona to utilize GI Genius – a powerful ally in the fight against colorectal cancer that employs artificial intelligence (AI) to help physicians detect polyps.
The GI Genius module uses advanced AI software to highlight suspicious polyps with a visual marker in real time—serving as the gastroenterologist’s ever-vigilant second observer with a sensitivity rate per lesion of 99.7%.1 Studies have shown that AI-assisted colonoscopy can increase polyp detection rates, and every 1% increase in adenoma detection rate reduces the risk of colorectal cancer by 3%.2,3 Colorectal cancer is the third most common form of cancer diagnosed in the U.S., with almost 150,000 new cases every year.
Trending
- Digital self-management programme for pain, fatigue and faecal incontinence in inflammatory bowel disease: cost-effectiveness analysis of the IBD-BOOST randomised controlled trial (BMJ)
- Clinicians Encouraged to ‘See C. diff Differently’ as Diagnostics, Resistance Patterns, and Therapeutic Tools Shift (GI & Endoscopy News)
- AGA, ACG Express Concerns About New American Cancer Society Recommendations (GI & Endoscopy News)
- In vitro development of the Autonomous Colonoscope Robot System (ACRS) for fully automated colonoscope insertion (Nature)
- Zobair Younossi, MD, on Global Consensus Recommendations for MASLD/MASH (HMP Global Learning Network )
- Recommending Blood Tests for CRC Without Guardrails Risks Confusion (MedPage Today)
- Gut Microbiome Could Remain Disrupted For Over a Decade After Polyp Removal (ScienceAlert)
- Why physician is not the same as provider (KevinMD)
